Market Pulse LIVECAST Terminal Movers Brief Politics Macro Calendar

More

Stocks About Why SquawkNews Newsroom Schedule Prediction Markets Disclosure Wire Crypto Search

Market Pulse LIVECAST

Menu

Home Market Pulse LIVECAST Terminal Movers Brief Politics Macro Calendar Stocks About Why SquawkNews Newsroom Schedule Prediction Markets Disclosure Wire Crypto Search

Live News REGULATION L impact Jul 22, 2026, 04:43 PM UTC

GSK reports Jideytro approved by FDA for ROS1-positive NSCLC

GSK announced the U.S....

SquawkNews Newsroom

GSK announced the U.S....

Use this page

Share or save this market-moving headline as a permanent SquawkNews URL. The live feed continues at /news.

Open live news feed Browse news archive Browse news categories Search related coverage

Related tickers

GSK

Related stories

Watch CRM YUM MCD WEN CAVA SG etc on headlines FDA Reports New Outbreak of Cyclospora Watch CRM YUM MCD WEN CAVA SG etc on headlines FDA Reports New Outbreak of Cyclospora L impact | REGULATION | Jul 22, 2026, 06:57 PM UTC FDA Reports New Outbreak of Cyclospora Linked to a Not Yet Identified Product. FDA Reports New Outbreak of Cyclospora Linked to a Not Yet Identified Product. L impact | REGULATION | Jul 22, 2026, 06:50 PM UTC PEN Penumbra reports THUNDER study results for THUNDERBOLT stroke device Penumbra released THUNDER IDE study results for its THUNDERBOLT Com PEN Penumbra reports THUNDER study results for THUNDERBOLT stroke device Penumbra released THUNDER IDE study results for its THUNDERBOLT Computer-assisted vacuum thrombectomy syste L impact | REGULATION | Jul 22, 2026, 06:43 PM UTC DXCM US FDA - selects DexCom as first tempo pilot participant for glucose health program - To select up to Ten tempo pilot participants per DXCM US FDA - selects DexCom as first tempo pilot participant for glucose health program - To select up to Ten tempo pilot participants per access model clinical use area L impact | REGULATION | Jul 22, 2026, 06:11 PM UTC DexCom selected by FDA as first participant in TEMPO pilot The U.S. Food and Drug... L impact | REGULATION | Jul 22, 2026, 06:06 PM UTC ISRG lows -2.6% and MDT -0.5% after earlier JNJ announced the FDA authorization for its Ottava Surgical Robot, marking its entry into the U. ISRG lows -2.6% and MDT -0.5% after earlier JNJ announced the FDA authorization for its Ottava Surgical Robot, marking its entry into the U.S. robotic soft-tissue Surgery market L impact | REGULATION | Jul 22, 2026, 04:46 PM UTC

SQUAWK/NEWS

Real-time financial news agency. Market-moving headlines, macro, politics, filings and audio squawk built for traders.

Pro plan coming — join the list.

Product

LiveCast
Terminal
Brief
Macro
Calendar
Search

For Traders

Market Movers
News for Traders
How to Trade News
What Is a Squawk
Market Pulse
Disclosure Wire

Company

About
Why SquawkNews
Newsroom
Editorial Standards
Corrections
Contact

Legal

Privacy Policy
Terms of Use

© 2026 SquawkNews robots / sitemap SquawkNews publishes factual market information and context. It is not investment advice and does not provide trade recommendations.

We use analytics (GA4, Clarity, PostHog) to improve the product. Privacy Policy